Vitamin A status of children with a history of respiratory syncytial virus infection in infancy

Abstract
In order to extend our earlier observation that children who experience frequent respiratory episodes may benefit from Vitamin A supplementation, 206 children aged 2-7 years who had been hospitalized for broncholitis during infancy were randomized into a controlled trial of Vitamin A supplementation. Of these, 149 met the the criteria of protocol compliance after 12 months of follow-up. Mean plasma retinol at basline was 39.2 .mu.g/100 ml (s.e.m. = 1.0) and did not increase after 12 months (mean 36.0 .mu.g/100 ml, s.e.m. = 0.7) despite the older age of the cohort. The range observed (11.7-73.9 .mu.g/100 ml) included some children at risk of marginal Vitamin A deficiency. Mean plasma retinol levels were 20% lower than those of children experiencing frequent respiratory episodes recored earlier. Oral supplementation did not change plasma retinol levels, nor did it affect respiratory morbidity.